ScholarLens Back to search
2007•Zhongguo yaofangRequires access

Compound Glycyrrhizin for Chronic Hepatitis B:Observation of Clinical Efficacy

Guo Chun-hong

Open publisher page 0 citations

Abstract

OBJECTIVE:To observe the clinical efficacy of compound glycyrrhizin in the treatment of Chronic Hepatitis B.METHODS:A total of 90 patients with Chronic Hepatitis B were randomly divided into control group and trial group:with control group treated with routine hepatic protective therapy(vitamin C,vitamin B6,reduced glutathione sodium and Inosine Tablets),and the trial group treated with compound glycyrrhizin plus the routine therapy as adopted in the control group for 3 months.RESULTS:The improvement in both symptoms and signs in the trial group were significantly higher than in control group(P0.05),with the effective rates respectively at 87.5% and 61.9%(P0.05).CONCLUSION:The clinical efficacy of compound glycyrrhizin is satisfactory,and which plays an active role in hepatic protection and enzyme reduction.

About this research paper

What this paper is about

OBJECTIVE:To observe the clinical efficacy of compound glycyrrhizin in the treatment of Chronic Hepatitis B.METHODS:A total of 90 patients with Chronic Hepatitis B were randomly divided into control group and trial group:with control group treated with routine hepatic protective therapy(vitamin C,vitamin B6,reduced glutathione sodium and Inosine Tablets),and the trial group treated with compound glycyrrhizin plus the routine therapy as adopted in the control group for 3 months.RESULTS:The improvement in both symptoms and signs in the trial group were significantly higher than in control group(P0.05),with the effective rates respectively at 87.5% and 61.9%(P0.05).CONCLUSION:The clinical efficacy of compound glycyrrhizin is satisfactory,and which plays an active role in hepatic protection and enzyme reduction.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE:To observe the clinical efficacy of compound glycyrrhizin in the treatment of Chronic Hepatitis B.METHODS:A total of 90 patients with Chronic Hepatitis B were randomly divided into control group and trial group:with control group treated with routine hepatic protective therapy(vitamin C,vitamin B6,reduced glutathione sodium and Inosine Tablets),and the trial group treated with compound glycyrrhizin plus the routine therapy as adopted in the control group for 3 months.RESULTS:The improvement in both symptoms and signs in the trial group were significantly higher than in control group(P0.05),with the effective rates respectively at 87.5% and 61.9%(P0.05).CONCLUSION:The clinical efficacy of compound glycyrrhizin is satisfactory,and which plays an active role in hepatic protection and enzyme reduction.

Key concepts: Glycyrrhizin, Medicine, Chronic hepatitis, Gastroenterology, Internal medicine, Clinical efficacy, Group B, Clinical trial

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Compound Glycyrrhizin for Chronic Hepatitis B:Observation of Clinical Efficacy — Research Paper | ScholarLens